REG - Oncimmune Hldngs PLC - PDMR Dealing
RNS Number : 1045MOncimmune Holdings PLC06 May 2020Oncimmune Holdings plc
("Oncimmune" or the "Company")
PDMR Dealing
Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, has been notified that Carsten Schroeder, PDMR and Non-Executive Director, has purchased 18,000 ordinary shares of £0.01 each in the Company ("Ordinary Shares") for 85 pence per share on 4 May 2020.
Following this transaction, Carsten has a total interest in the Company of 27,000 Ordinary Shares, representing approximately 0.04 per cent of the Company's issued Ordinary Share capital.
This announcement, including the notification below, is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Carsten Schroeder
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
213800HCYIWT6YPI1I02
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BYQ94H38
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price
Volume
£0.85
18,000
d)
Aggregated information
- Aggregated volume
Same as above
- Price
e)
Date of the transaction
4 May 2020
f)
Place of the transaction
London stock exchange, AIM
For further information:
Oncimmune Holdings plc
Ron Kirschner, General Counsel and Company Secretary
contact@oncimmune.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHKKABPOBKKQPK
Recent news on Oncimmune Holdings
See all newsREG - Oncimmune Hldgs PLC - Trading Update
AnnouncementREG - Oncimmune Hldgs PLC - Contract Win
AnnouncementREG - Oncimmune Hldgs PLC - US$1.5m Contract Win with Top 10 Pharma Company
AnnouncementREG - Oncimmune Hldgs PLC - Holding(s) in Company
AnnouncementREG - Oncimmune Hldgs PLC - Holding(s) in Company
Announcement